SCHEMBL24993576

SCHEMBL24993576

CCOc1ccc(-c2cnc(Oc3ccccc3)c(C(=O)OC)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ RAB9A P51151 4/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ PRKDC P78527 1/20 0.45
▸ ATR Q13535 1/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ POLB P06746 2/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ LTA4H P09960 1/20 0.44
▸ PLA2G2A P14555 1/20 0.44
▸ SCN2A Q99250 3/20 0.44
▸ SCN10A Q9Y5Y9 3/20 0.44
▸ KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24993566 0.88 ALDH1A1 (0.49) NPC1KDM4EMAPTRAB9AALDH1A1
SCHEMBL24994337 0.87 NPC1 (0.52) NPC1KDM4EMAPTRAB9AALDH1A1
SCHEMBL24993550 0.84 NPC1 (0.52) NPC1KDM4EMAPTRAB9AALDH1A1
SCHEMBL24993600 0.81 NPC1 (0.53) NPC1KDM4EMAPTRAB9AALDH1A1
SCHEMBL24993543 0.80 NPC1 (0.52) NPC1KDM4EMAPTRAB9AALDH1A1
SCHEMBL24994737 0.80 NPC1 (0.52) NPC1KDM4EMAPTRAB9AALDH1A1
SCHEMBL24994394 0.79 RAB9A (0.52) NPC1KDM4EMAPTRAB9AALDH1A1
SCHEMBL24993559 0.75 ALDH1A1 (0.53) NPC1KDM4EMAPTRAB9AALDH1A1
SCHEMBL31547771 0.75 RAB9A (0.57) NPC1KDM4ERAB9AALDH1A1LMNA
SCHEMBL24993563 0.74 MAPT (0.51) NPC1KDM4EMAPTRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010191-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback